The potential of biosimilar rituximab: reducing budgets and increasing access to treatment
The challenges of transplantation for patients with multiple myeloma (MM)
Germline predispositions in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Jane E. Churpek
How can doctors discuss CLL treatment options with patients?
Myeloma 2016: Panel discussion on the new treatment paradigm
Gareth Morgan et al.